Dj. Waxman, ROLE OF METABOLISM IN THE ACTIVATION OF DEHYDROEPIANDROSTERONE AS A PEROXISOME PROLIFERATOR, Journal of Endocrinology, 150, 1996, pp. 129-147
The adrenal steroid dehydroepiandrosterone (DHEA) stimulates a dramati
c increase in both the size and the number of peroxisomes present in l
iver when given at pharmacological doses to rodents. Structurally dive
rse chemicals including many fatty acids, hypolipidemic drugs and othe
r foreign chemicals, can also induce such a peroxisome proliferative r
esponse. This response is associated with a dramatic induction of pero
xisomal fatty acid beta-oxidation enzymes and microsomal cytochrome P4
50 4A fatty acid hydroxylases and, long-term, can lead to induction of
hepatocellular carcinoma. This review examines the underlying mechani
sms by which DHEA induces peroxisome proliferation and evaluates the p
ossible role of peroxisome proliferator-activated receptor (PPAR) in t
his process. Like DHEA, the 17 beta-reduced metabolite 5-androstene-3
beta,17 beta-diol (ADIOL) is an active peroxisome proliferator when ad
ministered in vivo, whereas androgenic and estrogenic metabolites of D
HEA are inactive. In primary rat hepatocytes, however, DHEA and ADIOL
are inactive as inducers of P450 4A and peroxisomal enzymes unless fir
st metabolized by steroid sulfotransferase to the 3 beta-sulfates, DHE
A-S and ADIOL-S. Investigations as to whether DHEA utilizes the same i
nduction mechanism employed by classic, foreign chemical peroxisome pr
oliferators, namely, activation of the intracellular receptor molecule
PPAR, have shown that DHEA-S and ADIOL-S are ineffective with respect
to PPAR activation in transient transfection/trans-activation assays.
This inactivity of DHEA-S in vitro suggests a requirement for specifi
c cellular transport or for further metabolism of the steroid which is
only met in liver cells. Alternatively, the action of DHEA-S may requ
ire accessory proteins or other nuclear factors that modulate the acti
vity of PPAR, such as retinoid X receptor (RXR), hepatocyte nuclear fa
ctor-4 (HNF-4) or chick ovalbumin upstream promoter transcription fact
or (COUP-TF). Investigations using Ca2+-channel blockers such as nicar
dipine suggest that there are important mechanistic similarities betwe
en the foreign chemical- and DHEA-S-stimulated induction responses, an
d support the hypothesis that these two classes of peroxisome prolifer
ators both activate Ca2+-dependent signaling pathways. Further studies
are required to ascertain whether this potential of DHEA and its sulf
ated metabolites to serve as physiological modulators of fatty acid me
tabolism and peroxisome enzyme expression contributes to the striking
anticarcinogenic and other useful chemoprotective properties that DHEA
is known to possess.